U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541729) titled 'Effect of Rosmarinus Officinalis Extract on Oxidative Stress and Inflammatory Biomarkers in Patients With Type 2 Diabetes(T2DM)' on March 17.
Brief Summary: This study will evaluate the effects of Rosmarinus officinalis (rosemary) extract on oxidative stress and inflammation in patients with type 2 diabetes. Participants will be randomly assigned to receive either rosemary extract or a placebo for 12 weeks. The study aims to determine whether rosemary extract can improve health markers related to oxidative stress, inflammation, and metabolic function.
Study Start Date: Sept. 20, 2025
Study Type: INTERVENTIONAL
Condition:
Type 2...